Impact of low dose tocilizumab on mortality rate in patients with COVID-19 related pneumonia.
Eur. J. Intern. Med. 2020 Jun 1; 76: 313531-35.
Tocilizumab for severe COVID-19: a systematic review and meta-analysis.
Int. J. Antimicrob. Agents. 2020 Sep 1; 56 (3): 106103.
Comparative Survival Analysis of Immunomodulatory Therapy for COVID-19 'Cytokine Storm'.
Chest. 2021 Mar 1; 159 (3): 933-948.